• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON UMBILICAL CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON UMBILICAL CATHETER Back to Search Results
Model Number 270.04
Device Problems Material Fragmentation (1261); Malposition of Device (2616); Positioning Problem (3009)
Patient Problems Hematoma (1884); Abdominal Distention (2601); Foreign Body In Patient (2687)
Event Date 01/21/2024
Event Type  Injury  
Manufacturer Narrative
From the description, this umbilical catheter was not inserted in correct position, therefore this serious adverse event is not linked to the quality of our device.These complications are associated with the placement of umbilical catheters.For information, all umbilical catheters are controlled , including 100% tests carried out on each catheter during the manufacturing process.These tests are as follows: the bluntness of the catheter tip , marking the catheters and tightness.Our devices are compliant to norm iso 10555-1.In the ifu there cautions as follows : control of positioning : always check the location of the catheter by radiography.For umbilical arterial catheterization, the catheter can be sited either in the high position between thoracic vertebrae t6 and t9 or the low position at l3 to l5 level though the higher position is associated with lower complication rates.From our historical analysis of complaints, these 3 last years on all umbilical catheter range code 270.Xx, there was no other occurrence of similar adverse event.The involved sample for investigation has been discarded.
 
Event Description
Preterm of 34 weeks, weight 1700 gr.3 days old.Umbilical catheter inserted on 18th january, position controlled by x-ray after its insertion.The position was in low position at t10 and +1cm was inserted until mark 8 of the umbilical catheter.No additional controlled by x-ray has been done.Deterioration in the clinical condition of the newborn on 21 january , with a distended abdomen, abdominal venous collateral circulation.Carrying out an x-ray of the abdomen and an abdominal ultrasound showing a left hepatic hematoma associated with a subcapsular hematoma appearing to have ruptured in the peritoneal cavity.The end of the ktvo is found at the level of the portal trunk.Surgical management not indicated.Removal of the poorly positioned ktvo and transfer to intensive care for further treatment.Hemorrhagic shock requiring a transfusion of 30 ml.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UMBILICAL CATHETER
Type of Device
UMBILICAL CATHETER
Manufacturer (Section D)
VYGON
5 rue
adeline, ecouen 95440
FR  95440
Manufacturer (Section G)
VYGON
5 rue
adeline, ecouen 95440
FR   95440
Manufacturer Contact
freda lacroix
2750 morris road
lansdale, PA 19446
8004735414
MDR Report Key18730750
MDR Text Key335721702
Report Number2245270-2024-00018
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K921374
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/19/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number270.04
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received01/30/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 DA
Patient Weight2 KG
-
-